QT Imaging Q2 Revenue Doubles to $7.4M, Reaffirms $39M Full-Year Guidance
QTI is trading near its 52-week low of $2.51 (15% above the low).
Summary
QT Imaging reported Q2 revenue of $7.4 million, more than double the prior-year period, with 15 scanners shipped in the quarter and 28 in the first half. First-half revenue rose 116% to $14.0 million. Management reaffirmed full-year 2026 revenue guidance of approximately $39 million, implying a significant second-half ramp. The company also completed a $10 million public offering, extended its term loan maturity by two years, and received regulatory authorizations in Israel and Saudi Arabia. A clean first FDA inspection and new manufacturing capacity support the commercial scale-up. The earnings call is scheduled for 4:30 p.m. ET today.
At the time of this announcement, QTI was trading at $2.88 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $41.4M. The 52-week trading range was $2.51 to $9.21. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.